
Emerging Global Hubs in Biotech: Where Should You Be Looking?
Funding cycles in biotech are notoriously volatile. When capital tightens, companies often shift into “survival mode”—freezing headcount, extending runways, and scrutinizing every hire. Job postings decline, competition for roles intensifies, and candidates become more cautious.




